| 查看: 719 | 回复: 7 | ||||
[交流]
STM：靶向作用脂肪激素或可开发出治疗2型糖尿病的新型疗法
|
||||
|
12月23日，来自哈佛大学的一个研究团队通过研究描述了一种临床前的方法或可帮助治疗2型糖尿病、脂肪肝及其它代谢性疾病，文章中研究者开发了一种抗体，其可以改善通过靶向作用脂肪组织中名为aP2（FABP4）的激素来帮助改善机体的葡萄糖调节，并且降低肥胖小鼠集体的脂肪肝症状。 Development of a therapeutic monoclonal antibody that targets secreted fatty acid–binding protein aP2 to treat type 2 diabetes http://stm.sciencemag.org/content/7/319/319ra205 Kill the messenger A variety of metabolic messengers—many from adipose tissue itself—controls the energy state of organs and organisms. Recently, researchers showed that the fatty acid binding protein aP2, once thought to live and work only in the cytoplasm, is also secreted by adipose tissue and spurs metabolic changes in other organs. Now, Burak and colleagues test whether secreted aP2 can serve as a therapeutic target for type 2 diabetes. In mice, the secreted form of aP2 regulates glucose production in liver, systemic glucose homeostasis, and insulin resistance. Serum levels of aP2 were shown to be elevated in obese mice and humans and to correlate with metabolic complications. The authors identified a monoclonal antibody to aP2 that lowered fasting blood glucose, increased insulin sensitivity, and lowered both fat mass and fatty liver (steatosis) in obese mouse models, relative to a control antibody, but not in aP2-deficient mice. The antidiabetic effects of the therapeutic antibody were linked to the regulation of hepatic glucose output and peripheral glucose utilization. Together, these findings suggest that an aP2-targeted antibody that kills the messenger is a viable approach for diabetes treatment. Abstract The lipid chaperone aP2/FABP4 has been implicated in the pathology of many immunometabolic diseases, including diabetes in humans, but aP2 has not yet been targeted for therapeutic applications. aP2 is not only an intracellular protein but also an active adipokine that contributes to hyperglycemia by promoting hepatic gluconeogenesis and interfering with peripheral insulin action. Serum aP2 levels are markedly elevated in mouse and human obesity and strongly correlate with metabolic complications. These observations raise the possibility of a new strategy to treat metabolic disease by targeting serum aP2 with a monoclonal antibody (mAb) to aP2. We evaluated mAbs to aP2 and identified one, CA33, that lowered fasting blood glucose, improved systemic glucose metabolism, increased systemic insulin sensitivity, and reduced fat mass and liver steatosis in obese mouse models. We examined the structure of the aP2-CA33 complex and resolved the target epitope by crystallographic studies in comparison to another mAb that lacked efficacy in vivo. In hyperinsulinemic-euglycemic clamp studies, we found that the antidiabetic effect of CA33 was predominantly linked to the regulation of hepatic glucose output and peripheral glucose utilization. The antibody had no effect in aP2-deficient mice, demonstrating its target specificity. We conclude that an aP2 mAb–mediated therapeutic constitutes a feasible approach for the treatment of diabetes. |
回复此楼» 收录本帖的淘帖专辑推荐
 新药资讯 |
» 猜你喜欢
如何高效的测量腺病毒的粒径和电位
已经有0人回复
-
[求助] 流式死活染 & 单细胞门控设置被质疑，如何优化并解释？
已经有1人回复
-
药物学论文润色/翻译怎么收费?
已经有55人回复
-
蛋白稳定性实验与功能实验不一致
已经有11人回复
-
第4年了，马上40了，可能我与国基确实无缘吧。。。
已经有12人回复
-
2026年申博药学专业
已经有1人回复
-
26在职申博—生物与医药—抗体/ADC药物方向，江浙沪，有项目，可带资。
已经有1人回复
-
288分求调剂
已经有0人回复
-
一志愿苏州大学 生物技术与工程（086001） 初试323分，求调剂
已经有0人回复
-
三年实验室工作经历，一志愿华中农业大学微生物，总分288求调剂
已经有0人回复
» 抢金币啦！回帖就可以得到:
-
鲍红丽课题组 研究生招生启事
+1/477
-
山东征女友，坐标济南
+1/171
-
化学化工学院 招收化工、化学、材料等相关方向研究生（学硕、专硕都有调剂名额）
+1/83
-
郑州大学付永柱课题组诚招2026年入学博士生
+1/82
-
物理学 调剂
+1/81
-
【武汉高校】【新能源材料与器件课题组】 招收优秀硕士调剂生！！！
+5/60
-
青岛大学泰山学者课题组招2026年申请考核制博士
+1/34
-
清华大学环境学院贺克斌院士团队招聘博士后
+1/33
-
澳大利亚西澳大学（UWA）张金强课题组招收全奖博士生（化工新能源方向）
+1/33
-
【2026博士招生/博后招聘】北京航空航天大学潘彪课题组——AI芯片设计方向
+1/14
-
青岛科技大学0860 调剂招生
+1/13
-
山东省植物基蛋白技术创新中心课题组联合培养硕士研究生招募启事
+1/13
-
中国科学院地球化学研究所招科研助理
+1/9
-
西京学院土木水利 2026 级研究生招生相关说明
+1/8
-
课题组招收环境及相关专业调剂硕士研究生（欢迎优秀学生加入）
+1/8
-
青岛科技大学可持续高分子团队 考研招生
+1/7
-
中国民航飞行学院先进连接团队招收航空宇航、航空机械专业硕士研究生（学硕专硕均可）
+1/7
-
招收环工、环科、化工、应化、化学、生工、生物、材化等相关专业研究生，要求过国家线
+1/5
-
湖南大学2026博士招生-人工智能安全方向
+1/2
-
澳洲维多利亚大学计算机类全额奖学金博士招生 （邮箱+微信可联系）
+1/1
8楼2016-01-10 22:43:00
简单回复
jiantu2楼
2015-12-29 10:32
回复
linglingchen(金币+1): 谢谢参与
liangbk3楼
2015-12-29 11:05
回复
linglingchen(金币+1): 谢谢参与
tzynew4楼
2015-12-29 12:50
回复
linglingchen(金币+1): 谢谢参与
假大空5楼
2015-12-29 13:24
回复
linglingchen(金币+1): 谢谢参与
2015-12-29 13:42
回复
linglingchen(金币+1): 谢谢参与
好
2016-01-09 22:32
回复
1
